Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease

• MAJIMA Takafumi

  Department of Endocrinology and Metabolism, Rakuwakai Otowa Hospital

• KOMATSU Yasato

  Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine

• DOI Kentaro

  Department of Endocrinology and Metabolism, Rakuwakai Otowa Hospital

• TAKAGI Chieko

  Department of Endocrinology and Metabolism, Rakuwakai Otowa Hospital

• SHIGEMOTO Michika

  Department of Endocrinology and Metabolism, Rakuwakai Otowa Hospital

• FUKAO Atsushi

  Department of Psychosomatic Medicine, Rakuwakai Otowa Hospital

• MORIMOTO Takeshi

  Department of General Medicine, Kyoto University Graduate School of Medicine

• CORNERS Jerry

  Rakuwakai Otowa Hospital

• NAKAO Kazuwa

  Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine

収録刊行物

• Journal of bone and mineral metabolism

  Journal of bone and mineral metabolism 24 (2), 105-113, 2006-03-30

キーワード

• bisphosphonate
• Graves' disease
• thyroid hormones
• bone mineral density
• N-terminal telopeptide of type I collagen

詳細情報

• CRID: 1571417125360675072
• NII論文ID: 10018194188
• NII書誌ID: AA10747551
• ISSN: 09148779
• Web Site: https://search.jamas.or.jp/link/ui/2006312212
• 本文言語コード: en
• データソース種別:
  • CiNii Articles